Photographs by Maciek Miloch, Set Design by Zuza Slominska, Food Styling by Nadine Page, Prop Styling by Pawel Wyszynski.

Atlassian’s branding will feature prominently on the FW47 race cars driven by Alex Albon and Carlos Sainz for the 2025 season ...

We put the B Structural Volumizing and Lengthening Mascara to the test. Lady Gaga may be making headlines for ...

Equities research analysts at Zacks Research boosted their Q1 2026 earnings per share estimates for shares of Corcept Therapeutics in a research note issued on Monday, January 27th. Zacks Research ...

Having trouble finding a Sector - Health fund? Fidelity Advisor Biotechnology A (FBTAX) is a potential starting point. FBTAX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

The European Food Safety Authority (EFSA) has concluded that oil derived from the microalgae Schizochytrium limacinum (strain ATCC-20889) is safe for use in infant and follow-on formulas at DHA ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

Watch as Lewis Hamilton has first test in Ferrari F1 car Lewis Hamilton said his first test in a Ferrari Formula 1 car was "awe-inspiring" and "one of the best feelings of my life". The 40-year ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...

The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023. Moderna plans to move mRNA-1018 to a Phase 3 trial. Shares of Moderna (MRNA) took off Tuesday ...